Jupiter Endovascular Exits Stealth With $21M in New Financing to Fund Pivotal Trial for Pulmonary Embolism

[#item_full_content]MENLO PARK, Calif.–(BUSINESS WIRE)– #catheter–Jupiter Endovascular exits stealth mode with $21 million in new financing and Carl J. St. Bernard appointed as CEO.